Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration

Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration

The proliferation and activation of microglia, the resident macrophages in the brain, is a hallmark of many neurodegenerative diseases such as Alzheimer's disease (AD) and prion disease. Colony stimulating factor 1 receptor (CSF1R) is critically involved in regulating microglial proliferation,...

Full description

Bibliographic Details
Main Authors:	Juliane Obst, Emilie Simon, Maria Martin-Estebane, Elena Pipi, Liana M. Barkwill, Ivette Gonzalez-Rivera, Fergus Buchanan, Alan R. Prescott, Dorte Faust, Simon Fox, Janet Brownlees, Debra Taylor, V. Hugh Perry, Hugh Nuthall, Peter J. Atkinson, Eric Karran, Carol Routledge, Diego Gomez-Nicola
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-10-01
Series:	Frontiers in Immunology
Subjects:	CSF1R (colony-stimulating factor 1 receptor) prion disease tissue-resident macrophage chronic neurodegeneration proliferation
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.579000/full

Similar Items

Differential regulation of microglial states by colony stimulating factors
by: E. Richard Stanley, et al.
Published: (2023-10-01)

Don’t know what you got till it’s gone: microglial depletion and neurodegeneration
by: David Graykowski, et al.
Published: (2021-01-01)

Profiles of 14-3-3 and Total Tau in CSF Samples of Chinese Patients of Different Genetic Prion Diseases
by: Cao Chen, et al.
Published: (2019-09-01)

Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy
by: Liam Kempthorne, et al.
Published: (2020-05-01)

Microglial responses to CSF1 overexpression do not promote the expansion of other glial lineages
by: Ishani De, et al.
Published: (2021-07-01)

Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration
by: Carlo Scialò, et al.
Published: (2019-03-01)

The Role of Microglia in Prion Diseases: A Paradigm of Functional Diversity
by: Juliane Obst, et al.
Published: (2017-06-01)

MicroRNA Alterations in the Brain and Body Fluids of Humans and Animal Prion Disease Models: Current Status and Perspectives
by: Eirini Kanata, et al.
Published: (2018-07-01)

Pin1 and neurodegeneration: a new player for prion disorders?
by: Elisa Isopi, et al.
Published: (2015-07-01)

Brain abnormalities, neurodegeneration, and dysosteosclerosis (BANDDOS): new cases, systematic literature review, and associations with CSF1R-ALSP
by: Jarosław Dulski, et al.
Published: (2023-06-01)

Homozygous mutation in CSF1R causes brain abnormalities, neurodegeneration, and dysosteosclerosis (BANDDOS)
by: Hossein Daghagh, et al.
Published: (2023-05-01)

Subventricular zone/white matter microglia reconstitute the empty adult microglial niche in a dynamic wave
by: Lindsay A Hohsfield, et al.
Published: (2021-08-01)

Microglial replacement therapy: a potential therapeutic strategy for incurable CSF1R-related leukoencephalopathy
by: Jinming Han, et al.
Published: (2020-12-01)

Pharmacological Targeting of CSF1R Inhibits Microglial Proliferation and Aggravates the Progression of Cerebral Ischemic Pathology
by: Boru Hou, et al.
Published: (2020-10-01)

Dangerous Stops: Nonsense Mutations Can Dramatically Increase Frequency of Prion Conversion
by: Alexander A. Dergalev, et al.
Published: (2021-02-01)

Activation of microglial NADPH oxidase is synergistic with glial iNOS expression in inducing neuronal death: a dual-key mechanism of inflammatory neurodegeneration
by: Brown Guy C, et al.
Published: (2005-09-01)

Early postnatal microglial ablation in the Ccdc39 mouse model reveals adverse effects on brain development and in neonatal hydrocephalus
by: Farrah N. Brown, et al.
Published: (2023-06-01)

Deplete and repeat: microglial CSF1R inhibition and traumatic brain injury
by: Rebecca Boland, et al.
Published: (2024-02-01)

CSF1R Ligands IL-34 and CSF1 Are Differentially Required for Microglia Development and Maintenance in White and Gray Matter Brain Regions
by: Courtney Easley-Neal, et al.
Published: (2019-09-01)

Insights Into the Role of CSF1R in the Central Nervous System and Neurological Disorders
by: Banglian Hu, et al.
Published: (2021-11-01)

Snf1/AMPK promotes the formation of Kog1/Raptor-bodies to increase the activation threshold of TORC1 in budding yeast
by: James E Hughes Hallett, et al.
Published: (2015-10-01)

Editorial: Women in veterinary experimental and diagnostic pathology: 2021
by: Raquel Manzano, et al.
Published: (2023-04-01)

Prion protein protocols /
by: Hill, Andrew F.
Published: (2008)

Increased expression of CSF1 in patients with eosinophilic asthma
by: Lijuan Du, et al.
Published: (2023-05-01)

Impairment of Neuronal Mitochondrial Quality Control in Prion-Induced Neurodegeneration
by: Mo-Jong Kim, et al.
Published: (2022-09-01)

Oral Ingestion of Synthetically Generated Recombinant Prion Is Sufficient to Cause Prion Disease in Wild-Type Mice
by: Chenhua Pan, et al.
Published: (2020-08-01)

The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation
by: Shi Fushan, et al.
Published: (2012-07-01)

Protein Biomarkers for the Diagnosis of Alzheimer’s Disease at Different Stages of Neurodegeneration
by: Mar Pérez, et al.
Published: (2020-09-01)

CSF-1 and Notch signaling cooperate in macrophage instruction and tissue repair during peripheral limb ischemia
by: Tamar Kapanadze, et al.
Published: (2023-08-01)

A Novel Missense Mutation of the CSF1R Gene Causes Incurable CSF1R-Related Leukoencephalopathy: Case Report and Review of Literature
by: Chen J, et al.
Published: (2020-12-01)

CSF1R Inhibition Combined with GM-CSF Reprograms Macrophages and Disrupts Protumoral Interplays with AML Cells
by: Tatiana Smirnova, et al.
Published: (2021-10-01)

The regulation of exosome function in the CNS: implications for neurodegeneration
by: Francesca Properzi, et al.
Published: (2015-11-01)

How Do Yeast Cells Contend with Prions?
by: Reed B. Wickner, et al.
Published: (2020-07-01)

Complex proteinopathies and neurodegeneration: insights from the study of transmissible spongiform encephalopathies
by: Pedro Piccardo, et al.

Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease
by: Marta Vicente-Rodríguez, et al.
Published: (2023-04-01)

Monocyte activation in systemic Covid-19 infection: Assay and rationale
by: Fernando O. Martinez, et al.
Published: (2020-09-01)

Two Novel Intronic Mutations in the CSF1R Gene in Two Families With CSF1R-Microglial Encephalopathy
by: Jiwei Jiang, et al.
Published: (2022-05-01)

Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration
by: Nasir Uddin Mahbub, et al.
Published: (2024-02-01)

Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets
by: Stefano Thellung, et al.
Published: (2022-09-01)

α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration
by: Hisham Abdelmotilib, et al.
Published: (2017-09-01)